Citadel Advisors’s NOVONIX NVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Sell
173,000
-32,000
-16% -$31.1K ﹤0.01% 11866
2025
Q4
$207K Buy
+205,000
New +$291K ﹤0.01% 10972
2025
Q2
Sell
-7,100
Closed -$8.16K 14277
2025
Q1
$8.16K Buy
+7,100
New +$10K ﹤0.01% 13654

Other funds holding NVX

Citadel Advisors's NVX Position: Q1 2026 in Review

Citadel Advisors increased its NOVONIX (NVX) stake by 491% in Q1 2026, buying an estimated $215K and bringing the position to 266,401 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #11496.

Citadel Advisors first reported a position in NVX in Q1 2024 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold NVX as of Q1 2026.

  • Citadel Advisors held 266,401 shares of NOVONIX worth $184K as of Q1 2026.
  • Citadel Advisors bought 221,325 NOVONIX shares in Q1 2026, an estimated $215K.
  • NOVONIX made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11496 holding.
  • Citadel Advisors first reported a position in NOVONIX in Q1 2024 and has held it in 6 quarters since.
  • 32 funds tracked by Wall St. Rank held NOVONIX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.